3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma MLAB

Mesa Laboratories, Inc.

MLAB NASDAQ Biotech & Pharma

Stock factsheet

TickerMLAB
ExchangeNASDAQ
ISIN
WKN
SectorBiotech & Pharma
Size class Small Cap
Market capitalisation 564 Mio. USD As of 2026-08-03

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Mesa Laboratories develops and markets measurement, control and monitoring instruments for regulated industries such as pharmaceuticals, food and medical devices. Its product range includes sterilisation indicators, data loggers and calibration services. The company grows through organic development and strategic acquisitions.

Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.

Share price

Price data from TradingView, possibly delayed. Not investment advice.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Mesa Laboratories, Inc.MLAB NASDAQ564 Mio. USD
Zevra Therapeutics, Inc. ZVRANASDAQ 562 Mio. USD
Relmada Therapeutics, Inc. RLMDNASDAQ 557 Mio. USD
Altimmune, Inc. ALTNASDAQ 552 Mio. USD
Beta Bionics, Inc. BBNXNASDAQ 577 Mio. USD
Contineum Therapeutics, Inc. CTNMNASDAQ 579 Mio. USD
Immix Biopharma, Inc. IMMXNASDAQ 581 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.